Patient satisfaction and cost savings analysis of the telemedicine program within a neuro-oncology department
- PMID: 36367630
- PMCID: PMC9651094
- DOI: 10.1007/s11060-022-04173-7
Patient satisfaction and cost savings analysis of the telemedicine program within a neuro-oncology department
Abstract
Purpose: Unique challenges exist in the utilization of telemedicine for neurological and surgical specialties. We examined the differences in patient satisfaction for telemedicine versus in-person visits within a Neuro-Oncology Program to assess whether there was a difference between surgical and medical specialties. We also examined the potential cost savings benefits of utilizing telemedicine.
Methods: 1189 Press Ganey surveys in the Department of Neuro-Oncology (982 in-person and 207 telemedicine) by surgical and medical neuro-oncology patients between 04/01/2020 and 06/30/2021 were reviewed. Survey results were divided into 4 categories (Access, Provider, Technology (telemedicine only), and Overall Satisfaction). Results were analyzed for the impact of telemedicine versus in-person visits, and gender, age, insurance, and specialty. Cost savings were calculated based on potential travel distance and lost productivity.
Results: Survey results from telemedicine visits demonstrated that patients with private insurance returned higher scores in the Provider (p = 0.0089), Technology (p = 0.00187), and Overall (p = 0.00382) categories. Surgical patients returned higher scores for Access (p = 0.0015), Technology (p = 0.0002), and Overall (p = 0.0019). When comparing telemedicine to in-person scores, in-person scored higher in Provider (p = 0.0092) for all patients, while in-person scored higher in Access (p = 0.0252) amongst surgical patients. Cost analysis revealed that telemedicine allowed patients to save an average of 4.1 to 5.6 h per visit time and a potential cost savings of up to $223.3 ± 171.4.
Conclusion: Telemedicine yields equivalent patient satisfaction when employed in surgical as compared to medical Neuro-Oncology patients with the potential to lessen the financial and time burden on neuro-oncology patients.
Keywords: Cost savings; Neuro-oncology; Neurosurgery; Press Ganey; Telemedicine.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
The authors declare no competing interests.
Figures

References
-
- Daggubati LC, Eichberg DG, Ivan ME, Hanft S, Mansouri A, Komotar RJ, D’Amico RS, Zacharia BE. Telemedicine for Outpatient Neurosurgical Oncology Care: Lessons Learned for the Future During the COVID-19 Pandemic. World Neurosurg. 2020;139:e859–e863. doi: 10.1016/j.wneu.2020.05.140. - DOI - PMC - PubMed
-
- Fonkem E, Gatson NTN, Tadipatri R, Cole S, Azadi A, Sanchez M, Stefanowicz E. Telemedicine review in neuro-oncology: comparative experiential analysis for Barrow Neurological Institute and Geisinger Health during the 2020 COVID-19 pandemic. Neurooncol Pract. 2021;8:109–116. doi: 10.1093/nop/npaa066. - DOI - PMC - PubMed
-
- Goyal DKC, Divi SN, Schroeder GD, Pfeifer R, Canseco JA, Bowles DR, Nicholson KJ, Patel PD, Reyes AA, Radcliff KE, Kurd MF, Woods BI, Kaye ID, Rihn JA, Anderson DG, Hilibrand AS, Kepler CK, Harrop JS, Vaccaro AR. Development of a Telemedicine Neurological Examination for Spine Surgery: A Pilot Trial. Clin Spine Surg. 2020;33:355–369. doi: 10.1097/bsd.0000000000001066. - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical